
Medical affairs outsourcing trends and benefits
What is the outlook for medical affairs up to 2030, and what are the advantages for pharma and biotechs from outsourcing this function to external specialists?
What is the outlook for medical affairs up to 2030, and what are the advantages for pharma and biotechs from outsourcing this function to external specialists?
Medical affairs is an increasingly complex discipline. It is vital that the team is highly trained and able to adapt to an evolving environment, liaising effectively with stakeholders to communicate value and bring new treatments to the market. Read on to discover some of the challenges and trends affecting the sector.